选择性5-羟色胺再摄取抑制剂-话题@MedSci

#选择性5-羟色胺再摄取抑制剂#

6篇内容 | 1670人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2271883, encodeId=441e22e1883fe, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a> <a href='/topic/show?id=d8ce128310fa' target=_blank style='color:#2F92EE;'>#儿童青少年强迫症#</a>, objectTitle=J Am Acad Child Adolesc Psychiatry：选择性5-羟色胺再摄取抑制剂对轻中度儿童青少年强迫症疗效更优，重度患者获益有限, objectType=article, longId=884921, objectId=88388849216c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720686441614_92910.png, objectUrl=/article/show_article.do?id=88388849216c, replyNumber=0, likeNumber=18, createdTime=2025-07-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=88388849216c, moduleTitle=J Am Acad Child Adolesc Psychiatry：选择性5-羟色胺再摄取抑制剂对轻中度儿童青少年强迫症疗效更优，重度患者获益有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88388849216c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2265309, encodeId=79db22653095c, content=<a href='/topic/show?id=cc12502026b' target=_blank style='color:#2F92EE;'>#强迫症状#</a> <a href='/topic/show?id=1f5950199b7' target=_blank style='color:#2F92EE;'>#强迫症#</a> <a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=BJPsych | SSRIs 治疗成人强迫症疗效再评估：个体数据荟萃分析揭示小效应量与基线特征无关联, objectType=article, longId=877686, objectId=638c8e7686c4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720691758183_92910.jpg, objectUrl=/article/show_article.do?id=638c8e7686c4, replyNumber=0, likeNumber=28, createdTime=2025-05-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=638c8e7686c4, moduleTitle=BJPsych | SSRIs 治疗成人强迫症疗效再评估：个体数据荟萃分析揭示小效应量与基线特征无关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638c8e7686c4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1420604, encodeId=6ce214206045c, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=Stroke：选择性5-羟色胺再摄取抑制剂与非心源性缺血性卒中风险的关系, objectType=article, longId=295132, objectId=a31029513287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a31029513287, replyNumber=0, likeNumber=103, createdTime=2022-02-06, rootId=0, userName=liuyiping, userId=91ed3584304, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a31029513287, moduleTitle=Stroke：选择性5-羟色胺再摄取抑制剂与非心源性缺血性卒中风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a31029513287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420603, encodeId=36eb142060300, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=JAMA Neurol：选择性5-羟色胺再摄取抑制剂对卒中幸存患者卒中复发及抑郁症状的影响, objectType=article, longId=200128, objectId=56f2200128e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56f2200128e2, replyNumber=0, likeNumber=149, createdTime=2020-09-03, rootId=0, userName=liuyiping, userId=91ed3584304, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56f2200128e2, moduleTitle=JAMA Neurol：选择性5-羟色胺再摄取抑制剂对卒中幸存患者卒中复发及抑郁症状的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56f2200128e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420602, encodeId=f4f614206024b, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=Stroke：选择性5-羟色胺再摄取抑制剂与脑出血的风险和结局, objectType=article, longId=189364, objectId=2f7218936475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f7218936475, replyNumber=0, likeNumber=104, createdTime=2020-03-06, rootId=0, userName=liuyiping, userId=91ed3584304, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f7218936475, moduleTitle=Stroke：选择性5-羟色胺再摄取抑制剂与脑出血的风险和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f7218936475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420601, encodeId=3e3e142060188, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=JAMA：应激障碍、继自身免疫性疾病与选择性5-羟色胺再摄取抑制剂治疗, objectType=article, longId=141174, objectId=966a1411e472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=966a1411e472, replyNumber=0, likeNumber=97, createdTime=2018-06-22, rootId=0, userName=liuyiping, userId=91ed3584304, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=966a1411e472, moduleTitle=JAMA：应激障碍、继自身免疫性疾病与选择性5-羟色胺再摄取抑制剂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=966a1411e472)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420600, encodeId=1a3b142060009, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=Stroke：选择性5-羟色胺再摄取抑制剂对脑卒中患者溶栓治疗后脑出血和预后的影响！, objectType=article, longId=119744, objectId=d6f6119e44aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6f6119e44aa, replyNumber=0, likeNumber=91, createdTime=2017-11-13, rootId=0, userName=liuyiping, userId=91ed3584304, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6f6119e44aa, moduleTitle=Stroke：选择性5-羟色胺再摄取抑制剂对脑卒中患者溶栓治疗后脑出血和预后的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6f6119e44aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420599, encodeId=e664142059907, content=<a href='/topic/show?id=be7994e8150' target=_blank style='color:#2F92EE;'>#选择性5-羟色胺再摄取抑制剂#</a>, objectTitle=BMJ：选择性5-羟色胺再摄取抑制剂联合他莫昔芬并不增加患者死亡的发生风险, objectType=article, longId=79162, objectId=4e2ee9162da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e2ee9162da, replyNumber=0, likeNumber=101, createdTime=2016-10-04, rootId=0, userName=liuyiping, userId=91ed3584304, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e2ee9162da, moduleTitle=BMJ：选择性5-羟色胺再摄取抑制剂联合他莫昔芬并不增加患者死亡的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e2ee9162da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

选择性5-羟色胺再摄取抑制剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂# #儿童青少年强迫症#

J Am Acad Child Adolesc Psychiatry：选择性5-羟色胺再摄取抑制剂对轻中度儿童青少年强迫症疗效更优，重度患者获益有限

2025-07-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#强迫症状# #强迫症# #选择性5-羟色胺再摄取抑制剂#

BJPsych | SSRIs 治疗成人强迫症疗效再评估：个体数据荟萃分析揭示小效应量与基线特征无关联

2025-05-16发表于上海

liuyiping (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂#

Stroke：选择性5-羟色胺再摄取抑制剂与非心源性缺血性卒中风险的关系

2022-02-06

liuyiping (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂#

JAMA Neurol：选择性5-羟色胺再摄取抑制剂对卒中幸存患者卒中复发及抑郁症状的影响

2020-09-03

liuyiping (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂#

Stroke：选择性5-羟色胺再摄取抑制剂与脑出血的风险和结局

2020-03-06

liuyiping (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂#

JAMA：应激障碍、继自身免疫性疾病与选择性5-羟色胺再摄取抑制剂治疗

2018-06-22

liuyiping (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂#

Stroke：选择性5-羟色胺再摄取抑制剂对脑卒中患者溶栓治疗后脑出血和预后的影响！

2017-11-13

liuyiping (审核中...)

前往app查看评论内容

#选择性5-羟色胺再摄取抑制剂#

BMJ：选择性5-羟色胺再摄取抑制剂联合他莫昔芬并不增加患者死亡的发生风险

2016-10-04

科室
- - 订阅+
  - 更多科室
工具
服务